Database
User
| Compound | Dose | Time | Species | Model | Method | Action | Result | Positive criterion | Reference |
|---|---|---|---|---|---|---|---|---|---|
| Mdivi-1 | inhibitor | Positive | 296 | ||||||
| Zidovudine | abnormalize | Positive | 307 | ||||||
| Acyclovir | abnormalize | Positive | 307 | ||||||
| Ganciclovir | abnormalize | Positive | 307 | ||||||
| Zalcitabine | abnormalize | Positive | 307 | ||||||
| XCT790 | inhibit | Positive | 308 | ||||||
| P110 | 1 µM | 30min | Cultured SH-SY5Y cells incubated with MPP+ (2 mM, for 4 hours) or CCCP (5 µM, for 30 minutes). The cells were then stained with anti-Tom20 antibody (green) and Hoechst stain. | microscopy images | inhibit | Positive | 310 | ||
| colchicine | Positive | 185 | |||||||
| docetaxel | Positive | 185 | |||||||
| Saquinavir | decrease | Positive | 307 | ||||||
| Rosiglitazone | 1, 2, 4, 7, 24, and 48 hrs | Murine | differentiated 3T3-L1 and C3H/10T1/2 adipocytes | increase | Positive | 179 | |||
| Rosiglitazone | 1uM | 24 and 48 hours | Murine | adipocytes | Mitochondrial Staining and Quantification | affect | Positive | 179 | |
| Clozapine | Increase | Positive | 307 | ||||||
| sertraline | decrease | Positive | 307 | ||||||
| Fluoxetine | decrease | Positive | 307 | ||||||
| sertraline | Change | Positive | 307 | ||||||
| Fluoxetine | Change | Positive | 307 | ||||||
| Berberine | isolated rat muscle mitochondria | decrease of absorbance at 540 nm with a Jasco V-560 spectrophotometer | increase | Positive | 327 | ||||
| Acetaminophen | > 200 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Acetylsalicylic acid | > 800 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Amantadine | > 800 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Ambroxol | > 400 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Amoxicillin | > 400 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Ampicillin | > 400 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Antipyrine | > 400 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Arsenic trioxide | > 200 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Biotin | 5.6 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| lumiracoxib | > 400 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| bisacodyl | > 400 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Bupivacaine | > 800 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Busulfan | > 800 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Butein | > 200 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Caffeine | > 400 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Capsaicin | > 200 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Carbamazepine | > 200 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Cefixime | > 400 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Chlorambucil | > 200 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Ciprofloxacin | > 400 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Clodronate | > 400 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| curcumin | > 200 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Daunorubicin | < 6.25 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| dexamethasone valerate | > 200 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Diazoxide | > 200 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Diclofenac | > 800 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Diflunisal | > 200 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Doxorubicin | 85 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Fluconazole | > 400 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Flufenamic Acid | > 200 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Flutamide | > 800 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| gefitinib | 63.6 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| genistein | > 200 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Gossypol | > 10 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Ibuprofen | > 200 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| imipramine | 274.4 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Indomethacin | > 800 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Isoniazid | > 800 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Ketoconazole | > 400 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Lamivudine | > 400 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Lidocaine | > 800 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Lonidamine | 660 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| lovastatin | 71.5 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| lumiracoxib | > 200 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Manganese | > 800 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Mefenamic acid | > 400 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Metformin | > 400 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Nicotine | > 400 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| nifuroxazide | > 400 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Nimesulide | > 200 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Nitrofurantoin | > 800 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Perhexiline | 14.8 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Piroxicam | > 200 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| pravastatin | > 200 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| propylparaben | > 800 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Pyrazinamide | > 400 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| resveratrol | > 200 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| riboflavin | 672.3 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| rifampicin | > 800 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Salicylic acid | > 400 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Simvastatin | 173.2 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Sulindac | > 200 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Tamoxifen | 9 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Tolcapone | > 400 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Tolfenamic Acid | > 800 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Troglitazone | > 200 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Valproic Acid | > 800 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Zidovudine | > 200 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | Positive | EC20 | 36 |
| Amiodarone | 100 μmol/L | rat; Sprague–Dawley | liver mitochondria | Measurements of mitochondrial swelling | increase | Positive | p < 0.05 | 4 | |
| benzarone | 100 μmol/L | rat; Sprague–Dawley | liver mitochondria | Measurements of mitochondrial swelling | increase | Positive | p < 0.05 | 4 | |
| benzbromarone | 100 μmol/L | rat; Sprague–Dawley | liver mitochondria | Measurements of mitochondrial swelling | increase | Positive | p < 0.05 | 4 | |
| Clozapine | Positive | 197 | |||||||
| Etoposide | isolated mitochondria | increase | Positive | 57 | |||||
| Cisplatin | Positive | 197 | |||||||
| Chlorpyrifos | 30 μM | Human | Human induced pluripotent stem cells (iPSCs) | increase | Positive | 242 | |||
| Paraquat | increase | Positive | 67 | ||||||
| Mdivi-1 | Positive | 248 | |||||||
| Urolithin A | enhance | Positive | 248 | ||||||
| Ozone | 1 μg O 3/mL | HeLa cells | Positive | 247 | |||||
| Ozone | 10 μg O 3/mL | HeLa cells | Positive | 247 | |||||
| Nicotine | 10 mM | Human | Human embryonal carcinoma cells (NT2/D1) | Positive | 247 | ||||
| Cisplatin | 3 mg/kg bodyweight | twice a week for 2 weeks | Mouse | Mouse tibial nerves and dorsal root ganglia (L1–L4) | Positive | 247 | |||
| Doxorubicin | 7.2 μM DXR for 24 hrs | Human | fibroblasts | Positive | 247 | ||||
| MDMA | 20 μM MDMA mixture for 24 hrs | Mouse primary hippocampal neurons | Positive | 247 | |||||
| Metamfetamine | 0.5, 1, 2 mM Meth for 24 hrs | Human neuroblastoma SH- SY5Y | Positive | 247 | |||||
| Troglitazone | 10 µM | ZDF fa/fa rat vs ZDF lean rat | isolated liver mitochondria | Mitochondrial swelling as an indicator of MPT was determined by the decrease in absorbance at 540 nm on a UV-2550 spectrophotometer. | induce | Positive | significantly different from ZDF lean rats (p < 0.05) | 225 | |
| Perfluorooctanoic acid | In utero exposure (GD 1–17) to 1 mg/kg bodyweight dam | Post-natal day 91 mouse livers | Positive | 247 | |||||
| Cadmium | In vitro: 12uM CdCl2 In vivo: 2mg/kg CdCl2 | Rat hepatocytes | Positive | 247 | |||||
| Manganese | Infusion of 1 μM MnCl2 | Rat glia | Positive | 247 | |||||
| Methylmercury | 20 μM | Human HepG2 cells | Positive | 247 | |||||
| Chlorpyrifos | 30 μM | Human stem cell-derived neural progenitor cells | Positive | 247 | |||||
| 2,4-dinitrophenol | 50 μM DNP at 3 hours post fertilization (hpf) | Danio rerio | Positive | 247 | |||||
| CCCP | 20 μM CCCP for 1 to 3 hours | HeLa cells | Positive | 247 | |||||
| FCCP | 10 μM FCCP for 48 to 72 hours | HeLa cells | Positive | 247 | |||||
| Ultraviolet B | 100 mJ/cm2 | human | Normal epidermal keratinocytes | Positive | 247 | ||||
| Ultraviolet C | 60 mJ/cm2 | Mouse | embryonic fibroblasts | Positive | 247 | ||||
| Wortmannin | 100 nM | SH-SY5Y neuroblastoma cells | Mitochondrial population levels were determined by flow cytometry using MitoTracker Deep Red (MTDR) dye. | Positive | 252 | ||||
| hydroxychloroquine | 30 μM | SH-SY5Y neuroblastoma cells | Mitochondrial population levels were determined by flow cytometry using MitoTracker Deep Red (MTDR) dye. | Positive | 252 | ||||
| Troglitazone | 10 µM | Wistar rat | Isolated rat liver mitochondria | Measurement of MPT using vesicle-fused mitochondria ( isolated mitochondria were preincubated with micellized phospholipid containing CL or CLOOH,and then a swelling assay was performed. ) | increase | Positive | 225 | ||
| Troglitazone | 25 µM | HepG2 cells | Images from transmission electron microscopy | abnormal | Positive | 332 | |||
| Troglitazone | 25 µM | HepG2 cells | confocal laser scanning microscopy (MitoTracker Red) | Positive | 332 | ||||
| 3-methyladenine | 10 mM | SH-SY5Y neuroblastoma cells | Mitochondrial population levels were determined by flow cytometry using MitoTracker Deep Red (MTDR) dye. | Positive | 252 | ||||
| Bafilomycin A1 | 50 nM | SH-SY5Y neuroblastoma cells | Mitochondrial population levels were determined by flow cytometry using MitoTracker Deep Red (MTDR) dye. | Positive | 252 | ||||
| CCCP | 10 μM or 25 μM | mouse embryonic fibroblasts (MEFs) and SH-SY5Y cells | Mitochondrial population levels were determined by flow cytometry using MitoTracker Deep Red (MTDR) dye. | Positive | 252 | ||||
| earle’s balanced salt solution | Positive | 252 | |||||||
| rapamycin | mouse | embryonic retinas | Mitochondrial population levels were determined by flow cytometry using MitoTracker Deep Red (MTDR) dye | Positive | 252 | ||||
| Cyclosporin A | 5 μM | mouse embryonic fibroblasts (MEFs) and SH-SY5Y cells | Mitochondrial population levels were determined by flow cytometry using MitoTracker Deep Red (MTDR) dye | block | Positive | 252 | |||
| Nicotinamide | 5 mM | 6h | SH-SY5Y cells | Mitochondrial population levels were determined by flow cytometry using MitoTracker Deep Red (MTDR) dye. | induce | Positive | 252 | ||
| fisetin | 10 μM | 6h | SH-SY5Y cells | Mitochondrial population levels were determined by flow cytometry using MitoTracker Deep Red (MTDR) dye. | induce | Positive | 252 | ||
| Dyclonine | mouse | neuron | Mitochondrial morphology and neurite area measurements | induce | Positive | 269 | |||
| Benoxinate | mouse | neuron | Mitochondrial morphology and neurite area measurements | induce | Positive | 269 | |||
| Phenyl aminosalicylate | mouse | neuron | Mitochondrial morphology and neurite area measurements | induce | Positive | 269 | |||
| genistein | mouse | neuron | Mitochondrial morphology and neurite area measurements | induce | Positive | 269 | |||
| Celecoxib | mouse | neuron | Mitochondrial morphology and neurite area measurements | induce | Positive | 269 | |||
| Yohimbine | mouse | neuron | Mitochondrial morphology and neurite area measurements | induce | Positive | 269 | |||
| penfluridol | mouse | neuron | Mitochondrial morphology and neurite area measurements | induce | Positive | 269 | |||
| pimozide | mouse | neuron | Mitochondrial morphology and neurite area measurements | induce | Positive | 269 | |||
| Doxepin | mouse | neuron | Mitochondrial morphology and neurite area measurements | induce | Positive | 269 | |||
| quercetin | HepG | Positive | 263 | ||||||
| quercetin | brain | Positive | 265 | ||||||
| piceatannol | 48hr | Mfn1−/− MEFs stably expressing an Mfn1 promoter reporter construct | Relative luciferase activity was determined in Mfn1−/− MEFs carrying the Mfn1 promoter reporter | Positive | 276 | ||||
| Nimesulide | 10 μM | 20 minutes | rat; Wistar; normal | liver mitochondria | Measurements of mitochondrial swelling | increase | Positive | ID50 | 12 |
| Nimesulide | 7.3 μM | 20 minutes | rat; Wistar; arthritis | liver mitochondria | Measurements of mitochondrial swelling | increase | Positive | ID50 | 12 |
| tacrolimus | beta cells from isolated rat islets | Transmission electron microscopy and 3D reconstruction of mitochondria | decrease | Positive | 322 | ||||
| Xanthohumol | 30μM | 24hr | MCF7 cells | using the MAP1LC3II/I ratio to monitor the autophagic flux; quantifiedPMPCB staining | block | Positive | 283 | ||
| doxycycline | 15 µg/ml | 6 days | 143B osteosarcoma cells | BN PAGE analysis, In-gel complex I activity and western blotting | inhibitor | Positive | 285 | ||
| Chloramphenicol | 50 μg/ml | 5 days | 143B osteosarcoma cells | Blue Native Gel | inhibitor | Positive | 286 | ||
| Chloramphenicol | 50µg/mL | 4 days | complex I de novo assembly analysed by BN-PAGE | inhibitor | Positive | 287 | |||
| MG-132 | 20 μM | 6 hr | HeLa cells | The cells were stained with MitoTracker Green FM and MitoSOX Red dyes followed by image acquisition on a confocal microscope. | induce | Positive | 291 | ||
| Hydrazine | 2 mM | 22-24 h | primary culture rat hepatocytes, RL-34(JCRB 0247), COS-1(JCRB 9082) IAR-20(JCRB 0610) | induce | Positive | 292 | |||
| H2O2 | 0.2mM | 22hr | rimary culture rat hepatocytes, RL-34,COS-1, IAR-20 | induce | Positive | 292 | |||
| Chloramphenicol | 200-300µg/ml | 22hr | primary culture rat hepatocytes, RL-34,COS-1, IAR-20 | induce | Positive | 292 | |||
| Ethidium Bromide | 200-300 µg/ml, 2 | 22h | RL-34, COS-1, IAR-20L cells (mouse fibrob-lasts) | induce | Positive | 292 | |||
| Erythromycin | 200 µg/ml | 22 h | primary culture rat hepatocytes, RL-34,COS-1, IAR-20 | induce | Positive | 292 | |||
| Indomethacin | 0.3-0.5 mM | 22 h | primary culture rat hep-atocytes, RL-34,COS-1, IAR-20 | induce | Positive | 292 | |||
| Ethanol | 12.5-500 mM | 5min | rat | cardiac myocytes | induce | Positive | 292 | ||
| Ethanol | 1-3% | 6hr | RL-34 | induce | Positive | 292 | |||
| Niclosamide | 1, 5, and 10 uM | 3 hr (1.5-6hr) | HeLa/mito-YFP | fluorescence microscope | induce | Positive | 294 | ||
| Diazepam | 140μg/ml | 16hr | PE cells | Energy-dependent accumulation of ethylrhodamine ; Electron micrographs of ultrathin sections | induce | Positive | 293 | ||
| Teriflunomide | induce | Positive | 295 | ||||||
| Leflunomide | 50 μM | 48 hr | HeLa cells, C2C12 muscle cells, MEF cells | Mfn2 and Mfn1 mRNA levels; MFN2, MFN1, and porin protein levels; images of mitochondrial morphology ; | induce | Positive | 295 | ||
| brequinar sodium | 1 μM | 48hr | C2C12 cells | induce | Positive | 295 | |||
| BGP-15 | 50 μM | 4hr | WRL-68 cells | Polyethylene glycol (PEG) fusion assay; OPA1 GTPase assay and OPA1-OPA1 interactions | induce | Positive | 297 | ||
| BGP-15 | 50 μM | 4hr | WRL-68 cells | mERFP-labeled WRL-68 cells | reduce | Positive | 297 | ||
| H2O2 | 10 μmol/10E7 cells | 4-6hr | C2C12 mouse | muscle myoblasts | detected by either MitoTracker Red staining, or by mERFP transfection | induce | Positive | 297 | |